Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial have?
Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial has 32 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial published?
Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial has 2022 year in the ScholarIQ index.
What is the open-access status of Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial?
Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial has bronze oa status in the ScholarIQ index.
What is the DOI of Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial?
The DOI for Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial is on the source record.
What is the PMID of Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial?
The PMID for Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial is on the source record.
What is the OpenAlex record for Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial?
The OpenAlex for Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial is on the source record.